Nephrotic syndrome Last edited: Apr 08, 2025
Content policy
Learned
Summary
Nephrotic syndrome is a collection of signs and symptoms indicating damage to the glomerular filtration barrier. It is
characterized by massive proteinuria (> 3.5 g/24 hours), hypoalbuminemia, and edema. In adults, the most common
include ( ) and . In children, nephrotic
syndrome is most commonly caused by ( ). Nephrotic syndrome can also be a manifestation of
advanced renal disease in systemic conditions (e.g., diabetic nephropathy or ). Typical laboratory findings of
nephrotic syndrome include hyperlipidemia and faKy casts on urinalysis. Treatment for , , and
usually includes immunosuppressive therapy. Nephrotic syndrome due to advanced renal disease is associated with a
worse prognosis and is more difficult to treat.
See the section “Core IM podcast 5 pearls on nephrotic syndrome” for their complete show notes on this topic.
COLLAPSE NOTES FEEDBACK
Definitions
Nephrotic-range proteinuria: proteinuria > 3.5 g/24 hours
Nephrotic syndrome: nephrotic-range proteinuria PLUS hypoalbuminemia and edema
COLLAPSE NOTES FEEDBACK
QBANK SESSION
causes of
nephrotic syndrome focal segmental glomerulosclerosis FSGS membranous nephropathy
minimal change disease MCD
amyloid nephropathy
FSGS membranous nephropathy
MCD
CoreIM podcast: 5
Pearls on Nephrotic
Syndrome
Nephritic and
nephrotic syn-
dromes
[1]
[1]
OPTIONS
High-yield Standard Clinician Key exam info on EN
Urine protein quantification cutoffs for nephrotic-range proteinuria are somewhat arbitrarily defined (cutoffs used in the literature
usually vary from 3.0–3.5 g/24 hoursor spot urine protein/creatinine ratio 3.0–3.5 g/g). Some patients with nephrotic syndrome may
present with protein uriaslightly below traditional cutoff values.
Overview
MAXIMIZE TABLE TABLE QUIZ
Differential diagnoses of nephrotic syndrome
Disease Epidemiology Associations Findings Treatment
Minimal change
disease (
)
Most common cause of nephrotic
syndrome in children
O@en idiopathic
Secondary causes (rare)
Immune stimulus (e.g.,
infection,
immunization)
Tumors (e.g., Hodgkin
lymphoma)
Certain drugs (e.g.,
NSAIDs)
LM: no changes (possibly fat bodies in
some proximal tubular cells)
IM: negative
EM: effacement of podocyte foot
processes
Selective glomerular proteinuria
Responds well to prednisone
Good prognosis
Focal segmental
glomerulosclerosis
Most common cause of nephrotic
syndrome in adults, especially in
African American and Hispanic
populations
Can be idiopathic
Heroin use
HIV infection
Sickle cell disease
Massive obesity
Interferon treatment
Congenital malformations
(e.g., Charcot-Marie-Tooth
syndrome)
NPHS1 and NHPS2
mutations
LM: segmental sclerosis and
hyalinosis
IM
Most commonly negative
Possibly IgM, C1, and C3 deposits
inside the sclerotic regions
EM: effacement of podocyte foot
processes (similar to
)
Prednisone (o@en shows poor
response)
If necessary, PLUS other
immunosuppressants (e.g.,
cyclosporine, tacrolimus)
RAAS inhibitors
Usually leads to ESRD if le@
untreated
Membranous
nephropathy
Most common cause of nephrotic
syndrome in adults of European,
Middle Eastern, or North African
descent
Primary:
Secondary:
Infections (HBV, HCV,
malaria, syphilis)
Autoimmune diseases
(e.g., SLE)
Tumors (e.g., lung
cancer, prostate
cancer)
Medications (e.g.,
NSAIDs, penicillamine,
gold)
LM
Diffuse thickened glomerular
capillary loops and basement
membrane
Granular subepithelial deposits
of IgG and C3 (dense
deposits) → spike and dome
appearance
RAAS inhibitors
Prednisone (o@en shows poor
response)
PLUS other
immunosuppressants (e.g.,
cyclophosphamide) in severe
disease
Usually leads to ESRD if le@
untreated
Diabetic nephropathy
Leading cause of ESRD in high-
income countries
Usually additional signs of
other organ system
complications (e.g.,
retinopathy, neuropathy)
LM
Thickening of the glomerular
basement membrane (increased
permeability)
Eosinophilic nodular
glomerulosclerosis
(Kimmelstiel-Wilson nodules)
EM
Thickening of the glomerular
basement membrane
Mesangial matrix expansion
Stringent glycemic control
RAAS inhibitors
[2][3][4][5][6]
lipoid
nephrosis
[7]
[8][9] minimal change
disease
anti-PLA2R antibodies
[10]
I
2
G
End Stage Renal Disease
3
L
COLLAPSE NOTES FEEDBACK
Segmental effacement of
podocyte foot processes
Amyloid nephropathy
More commonly seen in elderly
patients
The kidney is the most
commonly affected organ
in systemic amyloidosis.
Other organs might be
involved simultaneously
(e.g., the heart).
Multiple myeloma(AL
amyloidosis)
Chronic inflammatory
disease, e.g., tuberculosis,
rheumatoid arthritis (AA
amyloidosis)
LM
Mesangial proliferation
Subendothelial and/or
subepithelial immune complex
deposition
Thickening of the capillary walls
(appear as wire loops)
Congo red stain: amyloid
deposition in the mesangium
showing apple-green
birefringence under polarized
light
Nodular glomerulosclerosis
IM: positive for AA protein (AA
amyloidosis), positive for kappa and
lambda light chains (AL amyloidosis)
EM: amyloid fibrils
Melphalan, corticosteroids
Treatment of underlying
disease (e.g., bone marrow
transplantation may be used
for multiple myeloma)
Membranoproliferative
glomerulonephritis
Usually manifests with nephritic sediment, which can indicate:
Nephritic-nephrotic syndrome: if there is concomitant nephrotic-range proteinuria (> 3.5 g/24 hours)
Pure nephritic syndrome: if there is no proteinuria or proteinuria is below nephrotic range (< 3.5 g/24 hours)
See “Nephritic syndrome.”
LM = light microscopy, IM = immunofluorescent microscopy, EM = electron microscopy
[11]
Minimal change disease Podocyte foot process-
es fusion in minimal
change disease
Focal segmental
glomerulosclerosis
(FSGS)
Focal segmental
glomerulosclerosis
Membranous
nephropathy
Membranous
nephropathy
Diabetic nephropathy Diabetic nephropathy Lupus nephritis Kidney involvement in
amyloidosis (2 of 2)
&
Etiology
Nephrotic syndrome may be caused by primary glomerular disorders (80–90% of cases) and/or systemic diseases and toxic exposures (10–20% of
cases).
Primary (idiopathic) forms: The following types of nephrotic syndrome are commonly associated with other conditions. See the “Overview” section.
Membranous nephropathy
Membranoproliferative glomerulonephritis (can manifest as nephrotic or nephritic syndrome)
Secondary forms
Diabetic nephropathy
: can be associated with multiple myeloma (AL amyloidosis) or chronic inflammatory disease such as rheumatoid arthritis
(AA amyloidosis)
Lupus nephritis (can manifest as nephrotic or nephritic syndrome)
COLLAPSE NOTES FEEDBACK
Pathophysiology
Damage of glomerular filtration barrier
: cytokine-mediated damage of podocytes
: sclerosis of glomeruli → damage and loss of podocytes
: Anti-phospholipase A2 receptor antibodies ( ) bind to PLA2R (an autoantigen in glomerular
podocytes) and thereby form immune complexes that activate the complement system, leading to podocyte injury.
Membranoproliferative glomerulonephritis: See “Pathophysiology” in “Nephritic syndrome.”
Diabetic glomerulonephropathy: See “Pathophysiology” in “Diabetic nephropathy.”
Deposition of amyloid (e.g., AL amyloidosis, AA amyloidosis) in various organs (the kidney is the most commonly involved organ)
Amyloid deposition in glomeruli → mesangial expansion → nodular sclerosis
Lupus nephritis: See “Pathophysiology” in “Lupus nephritis.”
Sequelae of glomerular filter damage
Structural damage of glomerular filtration barrier → massive renal loss of protein (hyperproteinuria) → reactively increased hepatic protein synthesis
Loss of negative charge of glomerular basement membrane → loss of selectivity of barrier (especially for negatively charged albumin)
[12]
Minimal change disease
Focal segmental glomerulosclerosis
Amyloid nephropathy
[13][14]
Minimal change disease
Focal segmental glomerulosclerosis
Membranous nephropathy anti-PLA2R antibodies
[15]
Amyloid nephropathy
[16]
is classically not associated with immune complex deposition.
FSGS
[13][14]
Although the pathophysiology of minimal change disease is not fully understood, it is
most likely due to circulating cytokinesfollowing a T-cell response.
S
&
S
S
S
/
Podocyte damage and fusion → nonselective proteinuria (except in , which manifests with selective glomerular
proteinuria)
If protein loss exceeds hepatic synthesis (usually with a loss of protein > 3.5 g/24 hours) → hypoproteinemia/hypoalbuminemia, initially with both
normal GFR and creatinine
↓ Serum albumin → ↓ colloid osmotic pressure → edema (especially if albumin levels are < 2.5 g/dL)
Loss of antithrombin III, protein C, and protein S, increased synthesis of fibrinogen, and loss of fluid into the extravascular space
→ hypercoagulability
Loss of transport proteins
Loss of thyroglobulin transport protein → thyroxin deficiency
Vitamin D binding protein → vitamin D deficiency
Loss of plasma proteins → ↓ plasma protein binding → increase in free plasma drug concentration, but drug toxicity is usually not increased
↑ Plasma levels of cholesterol, LDL, triglycerides, and lipoproteins (mainly LPA) to compensate for the loss of albumin → lipiduria (faPy casts)
Loss of immunoglobulins → increased risk of infection, especially Streptococcus pneumoniae infection (pulmonary edema also increases the risk for
S. pneumoniae infection)
Sodium retention → possible hypertension
COLLAPSE NOTES FEEDBACK
Clinical features
Classic manifestations
Massive proteinuria > 3.5 g/24 hours
Edema
Typically starts with periorbital edema
Peripheral edema (piPing)
Pleural effusion
Pericardial effusion
Ascites
In severe cases, anasarca
Hypoalbuminemia
Hyperlipidemia
minimal change disease
[7]
[13][14]
[17]
[18][19]
[20]
[21]
Cross section of renal
corpuscle
Renal glomeruli
Because the damaged glomeruli continue to operate at the normal filtration rate, the renal function parameters remain largely unchanged while proteins
are still released into the urine. Although the cause of lipiduriais not entirely understood, it is thought to involve increased permeability to lipoproteins.
Unlike edema related to heart failure, the edema in hypoalbuminemia does not follow gravity. Instead, it appears
throughout the entire body. The area around the eyes is usually the first clinically apparent localization of edema
because connective tissue in this area is particularly loose, making edema very noticeable.
Nephrotic vs. nephritic syndrome
Nephritic syndrome and nephrotic syndrome are both common clinical manifestations of glomerular diseases.
Both syndromes are composed of characteristic clinical (e.g., edema, hypertension) and laboratory findings (e.g., glomerular hematuria, massive
proteinuria), which result from damage to the glomeruli.
Glomerular diseases are usually categorized by the syndrome they cause, which is either nephritic or nephrotic.
[1][2]
MAXIMIZE TABLE TABLE QUIZ
Nephritic syndrome Nephrotic syndrome
Presentation
Proteinuria (< 3.5 g/day) (can be in nephrotic range in severe cases )
Hematuria with acanthocytes
RBC casts in urine
Mild to moderate edema
Oliguria
Azotemia
Hypertension
Sterile pyuria
Rapidly progressive glomerulonephritis (RPGN)
Heavy proteinuria (> 3.5 g/day)
Hypoalbuminemia
Generalized edema
Hyperlipidemia and faIy casts in urine → frothy urine
Hypertension
↑ Risk of thromboembolism: (via loss of antithrombin III)
↑ Risk of infection (via loss of IgG and tissue edema
which compromises the local blood supply and immune
response)
Pathophysiology
Inflammatory response within glomeruli → GBM disruption → loss of renally excreted RBCs
(acanthocytes) and ↓ GFR → hematuria, oliguria, azotemia, and ↑ renin → edema and
hypertension
Damage to podocytes → structural damage of glomerular
filtration barrier → massive renal loss of protein
Causes
Poststreptococcal glomerulonephritis
IgA nephropathy (Berger disease)
Granulomatosis with polyangiitis
Microscopic polyangiitis
Eosinophilic granulomatosis with polyangiitis
Goodpasture disease (anti-GBM disease)
Alport syndrome (hereditary nephritis)
Thin basement membrane disease
Lupus nephritis
Due to primary or secondary podocyte damage
Minimal change disease
Focal segmental glomerulosclerosis
Membranous nephropathy
Due to secondary podocyte damage
Diabetic nephropathy
Amyloid light-chain (AL) amyloidosis, light chain
deposition disease
Lupus nephritis
All glomerular diseases can lead to acute and chronic kidney failure.
Other clinical features
Hypercoagulable state with increased risk of thrombosis and embolic events (e.g., pulmonary embolism, )
Increased susceptibility to infection
Hypertension in some cases
Possibly frothy urine
Symptoms of hypocalcemia (e.g., tetany, paresthesia, muscle spasms)
Symptoms of the underlying disease (e.g., malar rash in lupus nephritis)
See also “Nephrotic vs. nephritic syndrome.”
COLLAPSE NOTES FEEDBACK
Diagnosis
Initial evaluation
Confirmation of
Qualitative assessment by urine dipstick (commonly used for screening)
Usually shows ≥ 3+ proteins
Hematuria may indicate concomitant glomerulonephritis.
Quantitative assessment of urine protein excretion
24-hour urine protein (test of choice): > 3.5 g/24 hours
Spot urine protein/creatinine ratio: > 3.5 g/g
Urine sediment microscopy
Nephrotic sediment
Lipiduria, faJy casts with Maltese cross appearance under polarized light
Renal tubular epithelial cell casts
Hematuria with acanthocytes and/or RBC casts may indicate concomitant glomerulonephritis (see “Diagnostics” in “Nephritic syndrome”).
Additional laboratory studies
CBC: ↑ Hb/Hct may indicate hemoconcentration
renal vein thrombosis
[12][22]
nephrotic-range proteinuria
[23][24][25]
[23][26]
[27]
Maltese cross sign
Dipsticks have an increased sensitivity to albumin and the test may be falsely negativeif proteinuria is mainly
due to excess immunoglobulins (e.g., Bence-Jones proteinsin multiple myeloma). False-positiveproteinuria
may occur in the setting of concentrated urine (as indicated by high specific gravity).
Test of choice for establishing a quantitative proteinuria baseline and monitoring treatment. 24-hour
urine collection more accurately quantifies protein excretion than the spot urine protein/creatinine
ratio, especially at very high levels of proteinuriaand when proteinuria is subnephrotic.
BMP: ↑ Cr and/or ↑ BUN may be seen; ↓ Na is commonly seen.
Serum protein: ↓ total protein, ↓ albumin (< 3 g/dL)
Coagulation factors: ↓ ATIII, ↓ protein S, ↓ plasminogen ; ↑ fibrinogen, ↑ D-dimer
Lipid profile: Hyperlipidemia (↑ LDL, ↑ triglycerides) may be present.
Vitamin D levels: ↓ 25-OH Vit-D
Inflammatory markers: ↑ ESR, ↑ CRP may suggest underlying infection, inflammatory condition, or vasculitis.
Imaging
Renal ultrasound: to assess kidney size and shape and rule out obstruction
Subsequent evaluation
Additional testing to assess for potential concomitant conditions and underlying causes should be based on clinical suspicion.
[28][29]
[12][22]
[30]
MAXIMIZE TABLE TABLE QUIZ
Work-up for concomitant conditions and underlying
Suspected condition Recommended studies
Diabetic nephropathy
Serum glucose
HbA1c
Age-appropriate cancer screening
Lupus nephritis
ANA
Anti-dsDNA
C3, C4
Multiple myeloma
and other plasma cell dyscrasias
Serum protein electrophoresis and immune fixation
Urine protein electrophoresis and immune fixation
Chronic viral infection
HIV Ab
HBsAg
HCV Ab
Syphilis
RPR
FTA-ABS
Cryoglobulinemia
Cryoglobulins
C3, C4
Congenital nephrotic syndromes Genetic testing
causes of nephrotic syndrome
Membranous nephropathy
Anti-PLA R antibodies
2
Renal biopsy
Indication: to confirm the diagnosis when the etiology of nephrotic syndrome is unclear and/or to guide management
Interpretation: See the “Pathology” section.
COLLAPSE NOTES FEEDBACK
Pathology
Classification of nephrotic syndrome is based on the pa@ern of injury as seen on light microscopy (LM) of a renal biopsy specimen. For a complete
assessment, all biopsy specimens should be analyzed using LM, immunofluorescence microscopy (IM), and electron microscopy (EM).
EM: effacement of the foot processes of podocytes
LM: no changes in glomeruli (possibly fat bodies in some proximal tubular cells)
: damage to podocytes
EM: effacement of the foot processes (similar to )
LM: segmental sclerosis and hyalinosis and loss of podocytes
IM: rarely, focal deposits of IgM, C1, and C3 inside sclerotic lesion
: deposition of antibodies between podocytes and the basal membrane
EM: subepithelial dense deposits (IgG and C3) with a spike and dome appearance
LM: diffuse thickening of glomerular capillary loops and basal membrane
IM: granular subepithelial deposits of immune complexes and complement
Diabetic glomerulonephropathy: light microscopy shows mesangial matrix expansion, thickening of glomerular membrane, and/or nodular
eosinophilic glomerulosclerosis (Kimmelstiel-Wilson lesions)
Lupus nephritis: light microscopy shows mesangial proliferation, subendothelial and/or subepithelial immune complex deposition, and thickening of
the capillary walls (appear as wire loops)
EM: amyloid fibrils
LM
Nodular glomerulosclerosis
Apple-green birefringence (mesangial amyloid deposition) with Congo red stain under polarized light
Serum protein elec-
trophoresis in nephrotic
syndrome
[12][22]
Minimal change disease
Focal segmental glomerulosclerosis
minimal change disease
Membranous nephropathy
Amyloid nephropathy
COLLAPSE NOTES FEEDBACK
Treatment
Management of symptoms and complications of nephrotic syndrome
Edema
Dietary sodium restriction: < 3 g/day (usually 1.5–2 g/day)
Fluid restriction: < 1.5 liters/day
Diuretic therapy
Options
First-line: oral loop diuretic (e.g., furosemide)
Second-line:
Add oral thiazide or thiazide-like diuretic (e.g., metolazone)
AND/OR switch to IV loop diuretic (e.g., IV furosemide)
Consider adjunctive IV albumin
Proteinuria
Elimination or reduction of proteinuria is a major treatment goal for nephrotic syndrome and can lead to increased serum albumin, decreased edema,
aTenuation of the metabolic effects of heavy proteinuria (e.g., hyperlipidemia), reduction in risk of thromboembolism and infection, and slowing of the
progression of chronic kidney disease.
Antiproteinuric therapy
Indicated in most patients
RAAS inhibitor: ACEI (e.g., ramipril) or ARB (e.g., losartan) are commonly used.
Podocyte foot process-
es fusion in minimal
change disease
Minimal change disease Focal segmental
glomerulosclerosis
Focal segmental
glomerulosclerosis
(FSGS)
Membranous
nephropathy
Diabetic nephropathy
Diabetic nephropathy Lupus nephritis
[1][12][22]
[1][12][22]
[1][12]
[12][22]
[12][22]
[34]
[1][12][22]
[1][22][35]
Effects
Reduces proteinuria
Treats hypertension
May slow progression of any underlying renal disease (e.g., diabetic nephropathy)
Avoid in patients with AKI, hyperkalemia, or abrupt onset of nephrotic syndrome.
Other measures that may be beneficial in combination with an ACEI or ARB:
Low sodium diet
Thiazide diuretic (e.g., hydrochlorothiazide)
Mineralocorticoid receptor antagonist (e.g., spironolactone)
Dietary protein: avoid very high-protein diet but ensure adequate protein intake.
Dyslipidemia
Lipid-lowering therapy (e.g., atorvastatin)
Indications similar to those in other patients with a high risk of cardiovascular disease (See “Treatment” in “Lipid disorders”)
Hypercoagulability
All patients with nephrotic syndrome are at increased risk of thromboembolism, and this risk becomes progressively higher as serum albumin drops
below 3.0 g/L.
Prophylactic anticoagulation
Options
Unfractionated heparin
Low molecular weight heparin (e.g., enoxaparin)
Oral warfarin (target INR 2.0–3.0)
Evidence for direct oral anticoagulants (DOACs) is lacking; consider only in patients who are unable to tolerate unfractionated heparin, low
molecular weight heparin, or warfarin.
Infectious risk
Preventive measures
Pneumococcal vaccination
Annual vaccination for influenza
Disease-specific measures
Primary forms of nephrotic glomerulopathies: oen treated with immunosuppressive therapy
Immunosuppressive therapies may include:
Glucocorticoids (oen used initially)
Additional immunosuppressants (e.g., cyclophosphamide, calcineurin inhibitors) in patients with steroid-resistant nephrotic syndrome or severe
disease
Management in adults is usually guided by biopsy-based histological diagnosis.
Children are oen treated initially with empiric corticosteroids for presumed .
Secondary forms of nephrotic glomerulopathies: Treat the underlying cause.
[36]
[36]
[37]
[38]
[1][22][39]
[1][22][40]
[1][40]
[40]
[1][40]
[40]
[41]
[1]
[1][32]
MCD [42]
Primary
Initial management: conservative therapy including an RAAS inhibitor (i.e., ACEI or ARB)
Consider immunosuppressive therapy for severe or refractory disease.
Prednisone AND cyclophosphamide
Alternatives: cyclosporine, tacrolimus, OR rituximab
Primary (idiopathic) ( )
Initial management: supportive therapy including an RAAS inhibitor (i.e., ACEI or ARB).
Consider immunosuppressive therapy for all patients with nephrotic syndrome due to .
Prednisone
Alternative: calcineurin inhibitor (cyclosporin OR tacrolimus)
Primary (idiopathic) ( )
Initial management: immunosuppressive therapy
Prednisone
Alternative: cyclophosphamide OR calcineurin inhibitor
Diabetic nephropathy
Strict glycemic control
RAAS inhibition (e.g., ACEI or ARB)
Optimization of blood pressure control
Close surveillance and timely referral to renal replacement therapy if ESRD is anticipated
See “Diabetic nephropathy” for more information.
Treatment of the underlying disease
AL amyloidosis: treatment of multiple myeloma or other plasma cell dyscrasia
AA amyloidosis: treatment of underlying inflammatory condition
See “Amyloidosis” and “Multiple myeloma” for more information.
Lupus nephritis
See “Treatment” in “Lupus nephritis.”
COLLAPSE NOTES FEEDBACK
membranous nephropathy [1]
[1]
[1]
focal segmental glomerulosclerosis FSGS [1]
FSGS
[1]
minimal change disease MCD [1]
[1]
[43]
Amyloid nephropathy [44]
Complications
Thrombotic complications
Venous thromboembolism (e.g., deep vein thrombosis, pulmonary embolism)
Arterial thromboembolism
Renal vein thrombosis: thrombus formation in the renal veins or their branches
Cause: hypercoagulable state (e.g., malignancies, antiphospholipid syndrome, nephrotic syndrome)
Manifestations
Flank pain
Hematuria
↑ LDH
Anuria/renal failure in bilateral thrombosis
Scrotal edema
Diagnostics
CT angiography or MR venography (preferred modality in patients with renal injury or failure)
Doppler ultrasonography if no other diagnostic modality is available
Treatment
Anticoagulation
Thrombolysis or thrombectomy in selected patients
Complications: rupture of renal capsule, pulmonary embolism, kidney injury
Atherosclerotic complications
Abnormal lipid metabolism in combination with a hypercoagulable state leads to an increased risk of atherosclerotic complications
Manifestation: myocardial infarction, stroke
Chronic kidney disease
and in particular may progress to chronic kidney disease and ESRD.
Increased risk of infection
Most likely resulting from hypogammaglobulinemia caused by urinary protein loss
E.g., respiratory tract infections, peritonitis, urinary tract infections, sepsis
Especially with encapsulated bacteria (e.g., Streptococcus pneumoniae)
Protein malnutrition
Loss in lean body mass due to proteinuria may be masked by weight gain caused by concurrent edema.
[45]
[46]
[47]
[45][48]
FSGS membranous nephropathy
[49][50]
Vitamin D deficiency
Due to urinary loss of vitamin D binding protein (DBP) and bound 25-hydroxyvitamin D
Can cause hypocalcemia → ↑ serum parathyroid hormone (PTH) → bone disease (see “Secondary and tertiary hyperparathyroidism”)
Anemia
Due to urinary loss or impaired synthesis of transferrin (causing hypochromic microcytic anemia), transcobalamin (causing megaloblastic anemia),
copper (causing sideroblastic anemia), erythropoietin, and iron
We list the most important complications. The selection is not exhaustive.
COLLAPSE NOTES FEEDBACK
Differential diagnoses
See “Nephrotic vs. nephritic syndrome.”
Lupus nephritis (e.g., diffuse proliferative glomerulonephritis)
The differential diagnoses listed here are not exhaustive.
COLLAPSE NOTES FEEDBACK
Prognosis
The prognosis for is usually excellent.
With a wide variety of underlying diseases, the response to treatment can differ dramatically. Individuals with nephrotic syndrome oNen develop
progressive renal failure despite treatment and go on to require dialysis.
COLLAPSE NOTES FEEDBACK
[51][52][53]
[54]
[55]
minimal change disease
HINT USED
A 6-year-old boy is brought to the physician because of increasing swelling around his eyes for the past 3 days. During this period, he has had
frothy light yellow urine. He had a sore throat 12 days ago. He appears tired. His temperature is 37.0°C (98.6°F), pulse is 90/min, and blood
pressure is 105/65 mm Hg. Examination shows periorbital edema and piMing edema of the lower extremities. Cardiopulmonary examination shows
no abnormalities. Which of the following findings on urinalysis is most likely associated with this patient's condition?
ADD NOTES MARK GET ANKI CARDS
HINT USED
in combination with frothy urine is suggestive of . The most common cause of in children is
, which is most likely this child's diagnosis, especially considering his recent .
GIVE FEEDBACK
SHOW ALL EXPLANATIONS RESET QUESTION HIDE STATS
KEY INFO ATTENDING TIP LABS
Edema nephrotic syndrome nephrotic syndrome
minimal change disease pharyngitis
4%
A Epithelial casts
6%
B WBC casts
7%
C Waxy casts
12%
D Hyaline casts
20%
E RBC casts
3%
G Muddy brown casts
50%
FaDy casts are very common in the urinary sediment of patients with nephrotic syndrome. Massive proteinuria (> 3.5 g/24 h) results in
low serum albumin, which reduces capillary oncotic pressure, thereby causing edema secondary to fluid leaking into tissue. Consequently,
the liver increases all synthetic activity (involving albumin as well as other macromolecules, such as lipids) to compensate. Some of these
excess lipids are reabsorbed by the proximal tubular epithelial cells. Once the cytoplasm becomes engorged, chunks of the cell can slough
off into the tubular lumen, leading to the classic faMy casts on urinary sediment.
Patients with nephrotic syndrome are at high risk of developing infections (due to urinary loss of IgG), hypocalcemia (due to vitamin D
deficiency), and venous thrombus formation (due to urinary loss of antithrombin III and loss of fluid into the extravascular space).
Nephrotic syndrome GIVE FEEDBACK
F FaMy casts
Maltese cross
sign
EXIT SESSION NEXT
PREVIOUS
T
STUDENT Ctrl+K
Ask a medical question
frothy light yellow urine
periorbital edema and pitting edema of the lower extremities
A 5-year-old boy is brought to the physician because of facial swelling that started 5 days ago. Two weeks ago, he had a sore throat that resolved
spontaneously. His temperature is 37.0°C (98.6°F), pulse is 107/min, and blood pressure is 94/67 mm Hg. Examination shows piOing edema of the
upper and lower extremities as well as periorbital edema. The abdomen is mildly distended. Laboratory studies show:
A renal biopsy of this patient is most likely to show which of the following findings?
ADD NOTES MARK GET ANKI CARDS
HINT USED
Large , , , and are indicative of .
GIVE FEEDBACK
Hemoglobin 13.1 g/dL
Serum
Albumin 2.1 g/dL
Total cholesterol 290 mg/dL
Triglycerides 210 mg/dL
Urine
Blood negative
Glucose negative
Protein 4+
Leukocyte esterase negative
KEY INFO ATTENDING TIP LABS
proteinuria hypoalbuminemia edema hyperlipidemia nephrotic syndrome
1%
A SpliOing of the glomerular basement membrane on electron microscopy
2%
B Mesangial proliferation on light microscopy
5%
C Subepithelial dense deposits on electron microscopy
10%
D Deposits of IgG and C3 at the glomerular basement membrane on immunofluoresence
1%
E Linear deposition of anti-GBM antibodies on immunofluorescence
50%
This patient most likely has minimal change disease (MCD), which manifests without visible changes on light microscopy. In this
condition, circulating cytokines can cause effacement of podocytes, which is only visible on electron microscopy. MCD is the most
common cause of nephrotic syndrome in children (especially < 10 years of age). It may be triggered by a recent infection (as seen in this
case) or immunization. MCD responds very well to corticosteroids and has a good prognosis, which is why renal biopsy is usually not
indicated for diagnosis.
Nephrotic syndrome GIVE FEEDBACK
F Normal light microscopy findings
Minimal change
disease
EXIT SESSION PREVIOUS NEXT
T
STUDENT Ctrl+K
Ask a medical question
pitting edema
Albugin 215/01
To tal cholesterol 290 ms/dl
Protein At
SHOW ALL EXPLANATIONS RESET QUESTION HIDE STATS
7%
G Granular subepithelial deposits of IgG, IgM, and C3 on immunofluorescence
1%
H Apple-green birefringence with Congo red stain
23%
I Effacement of foot processes of podocytes on light microscopy
0%
J Segmental sclerosis on light microscopy
Nephrotic syndrome GIVE FEEDBACK
EXIT SESSION PREVIOUS NEXT
A 17-year-old boy is brought to the physician because of swelling of his face and legs for 5 days. He immigrated to the United States from Korea
with his family 10 years ago. He has been healthy except for an episode of sore throat 2 weeks ago. His younger sister has type 1 diabetes mellitus.
His temperature is 37.0°C (98.6°F), pulse is 90/min, and blood pressure is 145/87 mm Hg. Examination shows periorbital edema and 3+ piRing
edema of the lower extremities. Laboratory studies show:
Further evaluation is most likely to show which of the following additional findings?
ADD NOTES MARK GET ANKI CARDS
HINT USED
This boy has features of , i.e., swelling of the face and extremities, , and heavy (4+ on
), and that is positive for . frequently occurs in association with , which is more
common in some African and Asian countries (e.g., China and Korea).
GIVE FEEDBACK
Hemoglobin 13.9 g/dL
Leukocyte count 8100/mm
Serum
Glucose 78 mg/dL
Albumin 2.4 g/dL
Hepatitis B surface antigen positive
Hepatitis B surface antibody negative
Complement C4 decreased
Urine
Blood negative
Protein 4+
Glucose negative
Protein/creatinine ratio 8.1 (N ≤ 0.2)
3
KEY INFO ATTENDING TIP LABS
nephrotic syndrome hypoalbuminemia proteinuria urine
dipstick serology hepatitis B Membranous nephropathy hepatitis B
2%
B Eosinophilic nodules on renal biopsy
47%
Subepithelial deposits of IgG and complement along the glomerular basement membrane (spike and dome appearance) are the classic
finding in membranous nephropathy. The deposits can be seen on immunofluorescence microscopy and electron microscopy. In
secondary membranous nephropathy, subendothelial deposits are also commonly seen. While membranous nephropathy is the most
common cause of nephrotic syndrome in white adults, it is rare in the pediatric population. However, there are certain factors that
increase the risk of membranous nephropathy in children and adolescents as well, such as early hepatitis B infection, transmiRed either
vertically or horizontally.
While membranoproliferative glomerulonephritis (MPGN) is also associated with hepatitis B, it is less common than membranous
nephropathy and would show spliRing of basement membrane on renal biopsy.
Nephrotic syndrome GIVE FEEDBACK
A Subepithelial deposits on renal biopsy
Membranous
nephropathy
EXIT SESSION PREVIOUS NEXT
T
STUDENT Ctrl+K
Ask a medical question
swelling of his face and legs Korea
Albimin 2 . 48/dL
Hepatitis B surface antigen +
Ve
Protein 44
Protein
-
SHOW ALL EXPLANATIONS RESET QUESTION HIDE STATS
2%
B Eosinophilic nodules on renal biopsy
17%
C Antistreptolysin O titers in serum
4%
D Antineutrophil cytoplasmic antibody level in serum
26%
E Normal-appearing glomeruli on renal biopsy
5%
F Increased IgA levels in serum
EXIT SESSION PREVIOUS NEXT
-
-
HINT USED
A 7-year-old boy is brought to the physician by his mother for evaluation of progressively worsening swelling around the eyes. He has no history of
major medical illness. He had a sore throat and cough 2 weeks ago that resolved spontaneously. Physical examination shows moderate periorbital
edema and 2+ piBing edema of the lower extremities bilaterally. A kidney biopsy specimen shows effacement of the podocytes on electron
microscopy. Which of the following is most likely to be found on urinalysis?
ADD NOTES MARK GET ANKI CARDS
HINT USED
This patient's finding of effacement of the indicates ( ), the most common cause of
in children. A presentation of periorbital and a couple weeks a?er a potential viral infection (i.e., ) is
consistent with this diagnosis.
GIVE FEEDBACK
SHOW ALL EXPLANATIONS RESET QUESTION HIDE STATS
KEY INFO ATTENDING TIP LABS
biopsy podocytes minimal change disease MCD nephrotic
syndrome lower extremity edema sore throat
9%
A Hyaline casts and immunoglobulins
12%
B Red blood cell casts and acanthocytes
3%
D White blood cell casts and eosinophils
4%
E Granular casts and tubular epithelial cells
71%
FaBy casts and albumin are the expected findings in MCD, in which structural damage to the podocytes and loss of the GBM negative
charge results in a loss of protein (specifically, anionic albumin) into the urine. To compensate for the renal loss of albumin, the liver
increases lipoprotein synthesis. Lipids are then seen in the urine as faBy casts because of the increased glomerular permeability.
Nephrotic syndrome GIVE FEEDBACK
C FaBy casts and albumin
EXIT SESSION PREVIOUS NEXT
T
STUDENT Ctrl+K
Ask a medical question
swelling around the eyes.
effacement of the podocytes on electron
microscopy
An 8-year-old boy is brought to the office because of bilateral ankle swelling that occurred overnight. He has stopped wearing socks because they
feel too tight. He has type 1 diabetes mellitus treated with insulin. He has received all scheduled immunizations. His temperature is 37.0°C
(98.6°F), pulse is 90/min, respirations are 16/min, and blood pressure is 112/75 mm Hg. Cardiopulmonary and abdominal examinations show no
abnormalities. There is moderate scrotal edema, and 2+ piQing edema of the lower extremities. Laboratory studies show:
Treatment with prednisone is begun. Over the following weeks, there is a significant improvement in the patient's peripheral edema and urinalysis
findings. Which of the following is the most likely diagnosis?
ADD NOTES MARK GET ANKI CARDS
HINT USED
This patient's history of , , , and on indicates . In this patient, a
would most likely show with a normal appearance on light microscopy and effacement of foot processes on
.
GIVE FEEDBACK
Hemoglobin 13.5 g/dL
Leukocyte count 5000/mm
Platelet count 240,000/mm
Serum
Urea nitrogen 36 mg/dL
Glucose 77 mg/dL
Creatinine 0.8 mg/dL
Albumin 2.6 mg/dL
Urine
Blood negative
Glucose negative
Protein 4+
RBC none
WBC 0–1/hpf
FaQy casts numerous
3
3
KEY INFO ATTENDING TIP LABS
edema hypoalbuminemia proteinuria fa5y casts urinalysis nephrotic syndrome renal
biopsy glomeruli podocyte electron
microscopy
2%
A Nodular glomerulosclerosis
2%
B Membranoproliferative glomerulonephritis
1%
C IgA nephropathy
2%
E Focal segmental glomerulosclerosis
89%
Minimal change disease (MCD) is the most common cause of nephrotic syndrome in children. Immunosuppressive therapy is
recommended for all patients with MCD; glucocorticoid therapy (e.g., with prednisone) is considered the first-line treatment, as most
patients improve with this regimen alone. If complete remission does not occur, higher doses of steroid therapy or alternative
immunosuppressive agents (e.g., cyclophosphamide, calcineurin inhibitors) may be needed. Edema should be controlled by sodium
restriction and careful monitoring of fluid input and output.
MCD has also been associated with hematologic malignancies (e.g., Hodgkin lymphoma).
Nephrotic syndrome GIVE FEEDBACK
D Minimal change disease
EXIT SESSION PREVIOUS SEE ANALYSIS
T
STUDENT Ctrl+K
Ask a medical question
8-year-old boy
moderate scrotal edema
bilateral ankle swelling
2+ piQing edema of the lower extremities
Treatment with prednisone
Albumin 2
,
6 mild
Protein 4t
fatty casts numerous
SHOW ALL EXPLANATIONS RESET QUESTION HIDE STATS
2%
E Focal segmental glomerulosclerosis
5%
F Membranous nephropathy
EXIT SESSION PREVIOUS SEE ANALYSIS

Nephrotic syndrome. - AMBOSS.pdf

  • 1.
    Nephrotic syndrome Lastedited: Apr 08, 2025 Content policy Learned Summary Nephrotic syndrome is a collection of signs and symptoms indicating damage to the glomerular filtration barrier. It is characterized by massive proteinuria (> 3.5 g/24 hours), hypoalbuminemia, and edema. In adults, the most common include ( ) and . In children, nephrotic syndrome is most commonly caused by ( ). Nephrotic syndrome can also be a manifestation of advanced renal disease in systemic conditions (e.g., diabetic nephropathy or ). Typical laboratory findings of nephrotic syndrome include hyperlipidemia and faKy casts on urinalysis. Treatment for , , and usually includes immunosuppressive therapy. Nephrotic syndrome due to advanced renal disease is associated with a worse prognosis and is more difficult to treat. See the section “Core IM podcast 5 pearls on nephrotic syndrome” for their complete show notes on this topic. COLLAPSE NOTES FEEDBACK Definitions Nephrotic-range proteinuria: proteinuria > 3.5 g/24 hours Nephrotic syndrome: nephrotic-range proteinuria PLUS hypoalbuminemia and edema COLLAPSE NOTES FEEDBACK QBANK SESSION causes of nephrotic syndrome focal segmental glomerulosclerosis FSGS membranous nephropathy minimal change disease MCD amyloid nephropathy FSGS membranous nephropathy MCD CoreIM podcast: 5 Pearls on Nephrotic Syndrome Nephritic and nephrotic syn- dromes [1] [1] OPTIONS High-yield Standard Clinician Key exam info on EN Urine protein quantification cutoffs for nephrotic-range proteinuria are somewhat arbitrarily defined (cutoffs used in the literature usually vary from 3.0–3.5 g/24 hoursor spot urine protein/creatinine ratio 3.0–3.5 g/g). Some patients with nephrotic syndrome may present with protein uriaslightly below traditional cutoff values.
  • 2.
    Overview MAXIMIZE TABLE TABLEQUIZ Differential diagnoses of nephrotic syndrome Disease Epidemiology Associations Findings Treatment Minimal change disease ( ) Most common cause of nephrotic syndrome in children O@en idiopathic Secondary causes (rare) Immune stimulus (e.g., infection, immunization) Tumors (e.g., Hodgkin lymphoma) Certain drugs (e.g., NSAIDs) LM: no changes (possibly fat bodies in some proximal tubular cells) IM: negative EM: effacement of podocyte foot processes Selective glomerular proteinuria Responds well to prednisone Good prognosis Focal segmental glomerulosclerosis Most common cause of nephrotic syndrome in adults, especially in African American and Hispanic populations Can be idiopathic Heroin use HIV infection Sickle cell disease Massive obesity Interferon treatment Congenital malformations (e.g., Charcot-Marie-Tooth syndrome) NPHS1 and NHPS2 mutations LM: segmental sclerosis and hyalinosis IM Most commonly negative Possibly IgM, C1, and C3 deposits inside the sclerotic regions EM: effacement of podocyte foot processes (similar to ) Prednisone (o@en shows poor response) If necessary, PLUS other immunosuppressants (e.g., cyclosporine, tacrolimus) RAAS inhibitors Usually leads to ESRD if le@ untreated Membranous nephropathy Most common cause of nephrotic syndrome in adults of European, Middle Eastern, or North African descent Primary: Secondary: Infections (HBV, HCV, malaria, syphilis) Autoimmune diseases (e.g., SLE) Tumors (e.g., lung cancer, prostate cancer) Medications (e.g., NSAIDs, penicillamine, gold) LM Diffuse thickened glomerular capillary loops and basement membrane Granular subepithelial deposits of IgG and C3 (dense deposits) → spike and dome appearance RAAS inhibitors Prednisone (o@en shows poor response) PLUS other immunosuppressants (e.g., cyclophosphamide) in severe disease Usually leads to ESRD if le@ untreated Diabetic nephropathy Leading cause of ESRD in high- income countries Usually additional signs of other organ system complications (e.g., retinopathy, neuropathy) LM Thickening of the glomerular basement membrane (increased permeability) Eosinophilic nodular glomerulosclerosis (Kimmelstiel-Wilson nodules) EM Thickening of the glomerular basement membrane Mesangial matrix expansion Stringent glycemic control RAAS inhibitors [2][3][4][5][6] lipoid nephrosis [7] [8][9] minimal change disease anti-PLA2R antibodies [10] I 2 G End Stage Renal Disease 3 L
  • 3.
    COLLAPSE NOTES FEEDBACK Segmentaleffacement of podocyte foot processes Amyloid nephropathy More commonly seen in elderly patients The kidney is the most commonly affected organ in systemic amyloidosis. Other organs might be involved simultaneously (e.g., the heart). Multiple myeloma(AL amyloidosis) Chronic inflammatory disease, e.g., tuberculosis, rheumatoid arthritis (AA amyloidosis) LM Mesangial proliferation Subendothelial and/or subepithelial immune complex deposition Thickening of the capillary walls (appear as wire loops) Congo red stain: amyloid deposition in the mesangium showing apple-green birefringence under polarized light Nodular glomerulosclerosis IM: positive for AA protein (AA amyloidosis), positive for kappa and lambda light chains (AL amyloidosis) EM: amyloid fibrils Melphalan, corticosteroids Treatment of underlying disease (e.g., bone marrow transplantation may be used for multiple myeloma) Membranoproliferative glomerulonephritis Usually manifests with nephritic sediment, which can indicate: Nephritic-nephrotic syndrome: if there is concomitant nephrotic-range proteinuria (> 3.5 g/24 hours) Pure nephritic syndrome: if there is no proteinuria or proteinuria is below nephrotic range (< 3.5 g/24 hours) See “Nephritic syndrome.” LM = light microscopy, IM = immunofluorescent microscopy, EM = electron microscopy [11] Minimal change disease Podocyte foot process- es fusion in minimal change disease Focal segmental glomerulosclerosis (FSGS) Focal segmental glomerulosclerosis Membranous nephropathy Membranous nephropathy Diabetic nephropathy Diabetic nephropathy Lupus nephritis Kidney involvement in amyloidosis (2 of 2) &
  • 4.
    Etiology Nephrotic syndrome maybe caused by primary glomerular disorders (80–90% of cases) and/or systemic diseases and toxic exposures (10–20% of cases). Primary (idiopathic) forms: The following types of nephrotic syndrome are commonly associated with other conditions. See the “Overview” section. Membranous nephropathy Membranoproliferative glomerulonephritis (can manifest as nephrotic or nephritic syndrome) Secondary forms Diabetic nephropathy : can be associated with multiple myeloma (AL amyloidosis) or chronic inflammatory disease such as rheumatoid arthritis (AA amyloidosis) Lupus nephritis (can manifest as nephrotic or nephritic syndrome) COLLAPSE NOTES FEEDBACK Pathophysiology Damage of glomerular filtration barrier : cytokine-mediated damage of podocytes : sclerosis of glomeruli → damage and loss of podocytes : Anti-phospholipase A2 receptor antibodies ( ) bind to PLA2R (an autoantigen in glomerular podocytes) and thereby form immune complexes that activate the complement system, leading to podocyte injury. Membranoproliferative glomerulonephritis: See “Pathophysiology” in “Nephritic syndrome.” Diabetic glomerulonephropathy: See “Pathophysiology” in “Diabetic nephropathy.” Deposition of amyloid (e.g., AL amyloidosis, AA amyloidosis) in various organs (the kidney is the most commonly involved organ) Amyloid deposition in glomeruli → mesangial expansion → nodular sclerosis Lupus nephritis: See “Pathophysiology” in “Lupus nephritis.” Sequelae of glomerular filter damage Structural damage of glomerular filtration barrier → massive renal loss of protein (hyperproteinuria) → reactively increased hepatic protein synthesis Loss of negative charge of glomerular basement membrane → loss of selectivity of barrier (especially for negatively charged albumin) [12] Minimal change disease Focal segmental glomerulosclerosis Amyloid nephropathy [13][14] Minimal change disease Focal segmental glomerulosclerosis Membranous nephropathy anti-PLA2R antibodies [15] Amyloid nephropathy [16] is classically not associated with immune complex deposition. FSGS [13][14] Although the pathophysiology of minimal change disease is not fully understood, it is most likely due to circulating cytokinesfollowing a T-cell response. S & S S S /
  • 5.
    Podocyte damage andfusion → nonselective proteinuria (except in , which manifests with selective glomerular proteinuria) If protein loss exceeds hepatic synthesis (usually with a loss of protein > 3.5 g/24 hours) → hypoproteinemia/hypoalbuminemia, initially with both normal GFR and creatinine ↓ Serum albumin → ↓ colloid osmotic pressure → edema (especially if albumin levels are < 2.5 g/dL) Loss of antithrombin III, protein C, and protein S, increased synthesis of fibrinogen, and loss of fluid into the extravascular space → hypercoagulability Loss of transport proteins Loss of thyroglobulin transport protein → thyroxin deficiency Vitamin D binding protein → vitamin D deficiency Loss of plasma proteins → ↓ plasma protein binding → increase in free plasma drug concentration, but drug toxicity is usually not increased ↑ Plasma levels of cholesterol, LDL, triglycerides, and lipoproteins (mainly LPA) to compensate for the loss of albumin → lipiduria (faPy casts) Loss of immunoglobulins → increased risk of infection, especially Streptococcus pneumoniae infection (pulmonary edema also increases the risk for S. pneumoniae infection) Sodium retention → possible hypertension COLLAPSE NOTES FEEDBACK Clinical features Classic manifestations Massive proteinuria > 3.5 g/24 hours Edema Typically starts with periorbital edema Peripheral edema (piPing) Pleural effusion Pericardial effusion Ascites In severe cases, anasarca Hypoalbuminemia Hyperlipidemia minimal change disease [7] [13][14] [17] [18][19] [20] [21] Cross section of renal corpuscle Renal glomeruli Because the damaged glomeruli continue to operate at the normal filtration rate, the renal function parameters remain largely unchanged while proteins are still released into the urine. Although the cause of lipiduriais not entirely understood, it is thought to involve increased permeability to lipoproteins. Unlike edema related to heart failure, the edema in hypoalbuminemia does not follow gravity. Instead, it appears throughout the entire body. The area around the eyes is usually the first clinically apparent localization of edema because connective tissue in this area is particularly loose, making edema very noticeable.
  • 6.
    Nephrotic vs. nephriticsyndrome Nephritic syndrome and nephrotic syndrome are both common clinical manifestations of glomerular diseases. Both syndromes are composed of characteristic clinical (e.g., edema, hypertension) and laboratory findings (e.g., glomerular hematuria, massive proteinuria), which result from damage to the glomeruli. Glomerular diseases are usually categorized by the syndrome they cause, which is either nephritic or nephrotic. [1][2] MAXIMIZE TABLE TABLE QUIZ Nephritic syndrome Nephrotic syndrome Presentation Proteinuria (< 3.5 g/day) (can be in nephrotic range in severe cases ) Hematuria with acanthocytes RBC casts in urine Mild to moderate edema Oliguria Azotemia Hypertension Sterile pyuria Rapidly progressive glomerulonephritis (RPGN) Heavy proteinuria (> 3.5 g/day) Hypoalbuminemia Generalized edema Hyperlipidemia and faIy casts in urine → frothy urine Hypertension ↑ Risk of thromboembolism: (via loss of antithrombin III) ↑ Risk of infection (via loss of IgG and tissue edema which compromises the local blood supply and immune response) Pathophysiology Inflammatory response within glomeruli → GBM disruption → loss of renally excreted RBCs (acanthocytes) and ↓ GFR → hematuria, oliguria, azotemia, and ↑ renin → edema and hypertension Damage to podocytes → structural damage of glomerular filtration barrier → massive renal loss of protein Causes Poststreptococcal glomerulonephritis IgA nephropathy (Berger disease) Granulomatosis with polyangiitis Microscopic polyangiitis Eosinophilic granulomatosis with polyangiitis Goodpasture disease (anti-GBM disease) Alport syndrome (hereditary nephritis) Thin basement membrane disease Lupus nephritis Due to primary or secondary podocyte damage Minimal change disease Focal segmental glomerulosclerosis Membranous nephropathy Due to secondary podocyte damage Diabetic nephropathy Amyloid light-chain (AL) amyloidosis, light chain deposition disease Lupus nephritis All glomerular diseases can lead to acute and chronic kidney failure.
  • 7.
    Other clinical features Hypercoagulablestate with increased risk of thrombosis and embolic events (e.g., pulmonary embolism, ) Increased susceptibility to infection Hypertension in some cases Possibly frothy urine Symptoms of hypocalcemia (e.g., tetany, paresthesia, muscle spasms) Symptoms of the underlying disease (e.g., malar rash in lupus nephritis) See also “Nephrotic vs. nephritic syndrome.” COLLAPSE NOTES FEEDBACK Diagnosis Initial evaluation Confirmation of Qualitative assessment by urine dipstick (commonly used for screening) Usually shows ≥ 3+ proteins Hematuria may indicate concomitant glomerulonephritis. Quantitative assessment of urine protein excretion 24-hour urine protein (test of choice): > 3.5 g/24 hours Spot urine protein/creatinine ratio: > 3.5 g/g Urine sediment microscopy Nephrotic sediment Lipiduria, faJy casts with Maltese cross appearance under polarized light Renal tubular epithelial cell casts Hematuria with acanthocytes and/or RBC casts may indicate concomitant glomerulonephritis (see “Diagnostics” in “Nephritic syndrome”). Additional laboratory studies CBC: ↑ Hb/Hct may indicate hemoconcentration renal vein thrombosis [12][22] nephrotic-range proteinuria [23][24][25] [23][26] [27] Maltese cross sign Dipsticks have an increased sensitivity to albumin and the test may be falsely negativeif proteinuria is mainly due to excess immunoglobulins (e.g., Bence-Jones proteinsin multiple myeloma). False-positiveproteinuria may occur in the setting of concentrated urine (as indicated by high specific gravity). Test of choice for establishing a quantitative proteinuria baseline and monitoring treatment. 24-hour urine collection more accurately quantifies protein excretion than the spot urine protein/creatinine ratio, especially at very high levels of proteinuriaand when proteinuria is subnephrotic.
  • 8.
    BMP: ↑ Crand/or ↑ BUN may be seen; ↓ Na is commonly seen. Serum protein: ↓ total protein, ↓ albumin (< 3 g/dL) Coagulation factors: ↓ ATIII, ↓ protein S, ↓ plasminogen ; ↑ fibrinogen, ↑ D-dimer Lipid profile: Hyperlipidemia (↑ LDL, ↑ triglycerides) may be present. Vitamin D levels: ↓ 25-OH Vit-D Inflammatory markers: ↑ ESR, ↑ CRP may suggest underlying infection, inflammatory condition, or vasculitis. Imaging Renal ultrasound: to assess kidney size and shape and rule out obstruction Subsequent evaluation Additional testing to assess for potential concomitant conditions and underlying causes should be based on clinical suspicion. [28][29] [12][22] [30] MAXIMIZE TABLE TABLE QUIZ Work-up for concomitant conditions and underlying Suspected condition Recommended studies Diabetic nephropathy Serum glucose HbA1c Age-appropriate cancer screening Lupus nephritis ANA Anti-dsDNA C3, C4 Multiple myeloma and other plasma cell dyscrasias Serum protein electrophoresis and immune fixation Urine protein electrophoresis and immune fixation Chronic viral infection HIV Ab HBsAg HCV Ab Syphilis RPR FTA-ABS Cryoglobulinemia Cryoglobulins C3, C4 Congenital nephrotic syndromes Genetic testing causes of nephrotic syndrome Membranous nephropathy Anti-PLA R antibodies 2
  • 9.
    Renal biopsy Indication: toconfirm the diagnosis when the etiology of nephrotic syndrome is unclear and/or to guide management Interpretation: See the “Pathology” section. COLLAPSE NOTES FEEDBACK Pathology Classification of nephrotic syndrome is based on the pa@ern of injury as seen on light microscopy (LM) of a renal biopsy specimen. For a complete assessment, all biopsy specimens should be analyzed using LM, immunofluorescence microscopy (IM), and electron microscopy (EM). EM: effacement of the foot processes of podocytes LM: no changes in glomeruli (possibly fat bodies in some proximal tubular cells) : damage to podocytes EM: effacement of the foot processes (similar to ) LM: segmental sclerosis and hyalinosis and loss of podocytes IM: rarely, focal deposits of IgM, C1, and C3 inside sclerotic lesion : deposition of antibodies between podocytes and the basal membrane EM: subepithelial dense deposits (IgG and C3) with a spike and dome appearance LM: diffuse thickening of glomerular capillary loops and basal membrane IM: granular subepithelial deposits of immune complexes and complement Diabetic glomerulonephropathy: light microscopy shows mesangial matrix expansion, thickening of glomerular membrane, and/or nodular eosinophilic glomerulosclerosis (Kimmelstiel-Wilson lesions) Lupus nephritis: light microscopy shows mesangial proliferation, subendothelial and/or subepithelial immune complex deposition, and thickening of the capillary walls (appear as wire loops) EM: amyloid fibrils LM Nodular glomerulosclerosis Apple-green birefringence (mesangial amyloid deposition) with Congo red stain under polarized light Serum protein elec- trophoresis in nephrotic syndrome [12][22] Minimal change disease Focal segmental glomerulosclerosis minimal change disease Membranous nephropathy Amyloid nephropathy
  • 10.
    COLLAPSE NOTES FEEDBACK Treatment Managementof symptoms and complications of nephrotic syndrome Edema Dietary sodium restriction: < 3 g/day (usually 1.5–2 g/day) Fluid restriction: < 1.5 liters/day Diuretic therapy Options First-line: oral loop diuretic (e.g., furosemide) Second-line: Add oral thiazide or thiazide-like diuretic (e.g., metolazone) AND/OR switch to IV loop diuretic (e.g., IV furosemide) Consider adjunctive IV albumin Proteinuria Elimination or reduction of proteinuria is a major treatment goal for nephrotic syndrome and can lead to increased serum albumin, decreased edema, aTenuation of the metabolic effects of heavy proteinuria (e.g., hyperlipidemia), reduction in risk of thromboembolism and infection, and slowing of the progression of chronic kidney disease. Antiproteinuric therapy Indicated in most patients RAAS inhibitor: ACEI (e.g., ramipril) or ARB (e.g., losartan) are commonly used. Podocyte foot process- es fusion in minimal change disease Minimal change disease Focal segmental glomerulosclerosis Focal segmental glomerulosclerosis (FSGS) Membranous nephropathy Diabetic nephropathy Diabetic nephropathy Lupus nephritis [1][12][22] [1][12][22] [1][12] [12][22] [12][22] [34] [1][12][22] [1][22][35]
  • 11.
    Effects Reduces proteinuria Treats hypertension Mayslow progression of any underlying renal disease (e.g., diabetic nephropathy) Avoid in patients with AKI, hyperkalemia, or abrupt onset of nephrotic syndrome. Other measures that may be beneficial in combination with an ACEI or ARB: Low sodium diet Thiazide diuretic (e.g., hydrochlorothiazide) Mineralocorticoid receptor antagonist (e.g., spironolactone) Dietary protein: avoid very high-protein diet but ensure adequate protein intake. Dyslipidemia Lipid-lowering therapy (e.g., atorvastatin) Indications similar to those in other patients with a high risk of cardiovascular disease (See “Treatment” in “Lipid disorders”) Hypercoagulability All patients with nephrotic syndrome are at increased risk of thromboembolism, and this risk becomes progressively higher as serum albumin drops below 3.0 g/L. Prophylactic anticoagulation Options Unfractionated heparin Low molecular weight heparin (e.g., enoxaparin) Oral warfarin (target INR 2.0–3.0) Evidence for direct oral anticoagulants (DOACs) is lacking; consider only in patients who are unable to tolerate unfractionated heparin, low molecular weight heparin, or warfarin. Infectious risk Preventive measures Pneumococcal vaccination Annual vaccination for influenza Disease-specific measures Primary forms of nephrotic glomerulopathies: oen treated with immunosuppressive therapy Immunosuppressive therapies may include: Glucocorticoids (oen used initially) Additional immunosuppressants (e.g., cyclophosphamide, calcineurin inhibitors) in patients with steroid-resistant nephrotic syndrome or severe disease Management in adults is usually guided by biopsy-based histological diagnosis. Children are oen treated initially with empiric corticosteroids for presumed . Secondary forms of nephrotic glomerulopathies: Treat the underlying cause. [36] [36] [37] [38] [1][22][39] [1][22][40] [1][40] [40] [1][40] [40] [41] [1] [1][32] MCD [42]
  • 12.
    Primary Initial management: conservativetherapy including an RAAS inhibitor (i.e., ACEI or ARB) Consider immunosuppressive therapy for severe or refractory disease. Prednisone AND cyclophosphamide Alternatives: cyclosporine, tacrolimus, OR rituximab Primary (idiopathic) ( ) Initial management: supportive therapy including an RAAS inhibitor (i.e., ACEI or ARB). Consider immunosuppressive therapy for all patients with nephrotic syndrome due to . Prednisone Alternative: calcineurin inhibitor (cyclosporin OR tacrolimus) Primary (idiopathic) ( ) Initial management: immunosuppressive therapy Prednisone Alternative: cyclophosphamide OR calcineurin inhibitor Diabetic nephropathy Strict glycemic control RAAS inhibition (e.g., ACEI or ARB) Optimization of blood pressure control Close surveillance and timely referral to renal replacement therapy if ESRD is anticipated See “Diabetic nephropathy” for more information. Treatment of the underlying disease AL amyloidosis: treatment of multiple myeloma or other plasma cell dyscrasia AA amyloidosis: treatment of underlying inflammatory condition See “Amyloidosis” and “Multiple myeloma” for more information. Lupus nephritis See “Treatment” in “Lupus nephritis.” COLLAPSE NOTES FEEDBACK membranous nephropathy [1] [1] [1] focal segmental glomerulosclerosis FSGS [1] FSGS [1] minimal change disease MCD [1] [1] [43] Amyloid nephropathy [44]
  • 13.
    Complications Thrombotic complications Venous thromboembolism(e.g., deep vein thrombosis, pulmonary embolism) Arterial thromboembolism Renal vein thrombosis: thrombus formation in the renal veins or their branches Cause: hypercoagulable state (e.g., malignancies, antiphospholipid syndrome, nephrotic syndrome) Manifestations Flank pain Hematuria ↑ LDH Anuria/renal failure in bilateral thrombosis Scrotal edema Diagnostics CT angiography or MR venography (preferred modality in patients with renal injury or failure) Doppler ultrasonography if no other diagnostic modality is available Treatment Anticoagulation Thrombolysis or thrombectomy in selected patients Complications: rupture of renal capsule, pulmonary embolism, kidney injury Atherosclerotic complications Abnormal lipid metabolism in combination with a hypercoagulable state leads to an increased risk of atherosclerotic complications Manifestation: myocardial infarction, stroke Chronic kidney disease and in particular may progress to chronic kidney disease and ESRD. Increased risk of infection Most likely resulting from hypogammaglobulinemia caused by urinary protein loss E.g., respiratory tract infections, peritonitis, urinary tract infections, sepsis Especially with encapsulated bacteria (e.g., Streptococcus pneumoniae) Protein malnutrition Loss in lean body mass due to proteinuria may be masked by weight gain caused by concurrent edema. [45] [46] [47] [45][48] FSGS membranous nephropathy [49][50]
  • 14.
    Vitamin D deficiency Dueto urinary loss of vitamin D binding protein (DBP) and bound 25-hydroxyvitamin D Can cause hypocalcemia → ↑ serum parathyroid hormone (PTH) → bone disease (see “Secondary and tertiary hyperparathyroidism”) Anemia Due to urinary loss or impaired synthesis of transferrin (causing hypochromic microcytic anemia), transcobalamin (causing megaloblastic anemia), copper (causing sideroblastic anemia), erythropoietin, and iron We list the most important complications. The selection is not exhaustive. COLLAPSE NOTES FEEDBACK Differential diagnoses See “Nephrotic vs. nephritic syndrome.” Lupus nephritis (e.g., diffuse proliferative glomerulonephritis) The differential diagnoses listed here are not exhaustive. COLLAPSE NOTES FEEDBACK Prognosis The prognosis for is usually excellent. With a wide variety of underlying diseases, the response to treatment can differ dramatically. Individuals with nephrotic syndrome oNen develop progressive renal failure despite treatment and go on to require dialysis. COLLAPSE NOTES FEEDBACK [51][52][53] [54] [55] minimal change disease
  • 15.
    HINT USED A 6-year-oldboy is brought to the physician because of increasing swelling around his eyes for the past 3 days. During this period, he has had frothy light yellow urine. He had a sore throat 12 days ago. He appears tired. His temperature is 37.0°C (98.6°F), pulse is 90/min, and blood pressure is 105/65 mm Hg. Examination shows periorbital edema and piMing edema of the lower extremities. Cardiopulmonary examination shows no abnormalities. Which of the following findings on urinalysis is most likely associated with this patient's condition? ADD NOTES MARK GET ANKI CARDS HINT USED in combination with frothy urine is suggestive of . The most common cause of in children is , which is most likely this child's diagnosis, especially considering his recent . GIVE FEEDBACK SHOW ALL EXPLANATIONS RESET QUESTION HIDE STATS KEY INFO ATTENDING TIP LABS Edema nephrotic syndrome nephrotic syndrome minimal change disease pharyngitis 4% A Epithelial casts 6% B WBC casts 7% C Waxy casts 12% D Hyaline casts 20% E RBC casts 3% G Muddy brown casts 50% FaDy casts are very common in the urinary sediment of patients with nephrotic syndrome. Massive proteinuria (> 3.5 g/24 h) results in low serum albumin, which reduces capillary oncotic pressure, thereby causing edema secondary to fluid leaking into tissue. Consequently, the liver increases all synthetic activity (involving albumin as well as other macromolecules, such as lipids) to compensate. Some of these excess lipids are reabsorbed by the proximal tubular epithelial cells. Once the cytoplasm becomes engorged, chunks of the cell can slough off into the tubular lumen, leading to the classic faMy casts on urinary sediment. Patients with nephrotic syndrome are at high risk of developing infections (due to urinary loss of IgG), hypocalcemia (due to vitamin D deficiency), and venous thrombus formation (due to urinary loss of antithrombin III and loss of fluid into the extravascular space). Nephrotic syndrome GIVE FEEDBACK F FaMy casts Maltese cross sign EXIT SESSION NEXT PREVIOUS T STUDENT Ctrl+K Ask a medical question frothy light yellow urine periorbital edema and pitting edema of the lower extremities
  • 16.
    A 5-year-old boyis brought to the physician because of facial swelling that started 5 days ago. Two weeks ago, he had a sore throat that resolved spontaneously. His temperature is 37.0°C (98.6°F), pulse is 107/min, and blood pressure is 94/67 mm Hg. Examination shows piOing edema of the upper and lower extremities as well as periorbital edema. The abdomen is mildly distended. Laboratory studies show: A renal biopsy of this patient is most likely to show which of the following findings? ADD NOTES MARK GET ANKI CARDS HINT USED Large , , , and are indicative of . GIVE FEEDBACK Hemoglobin 13.1 g/dL Serum Albumin 2.1 g/dL Total cholesterol 290 mg/dL Triglycerides 210 mg/dL Urine Blood negative Glucose negative Protein 4+ Leukocyte esterase negative KEY INFO ATTENDING TIP LABS proteinuria hypoalbuminemia edema hyperlipidemia nephrotic syndrome 1% A SpliOing of the glomerular basement membrane on electron microscopy 2% B Mesangial proliferation on light microscopy 5% C Subepithelial dense deposits on electron microscopy 10% D Deposits of IgG and C3 at the glomerular basement membrane on immunofluoresence 1% E Linear deposition of anti-GBM antibodies on immunofluorescence 50% This patient most likely has minimal change disease (MCD), which manifests without visible changes on light microscopy. In this condition, circulating cytokines can cause effacement of podocytes, which is only visible on electron microscopy. MCD is the most common cause of nephrotic syndrome in children (especially < 10 years of age). It may be triggered by a recent infection (as seen in this case) or immunization. MCD responds very well to corticosteroids and has a good prognosis, which is why renal biopsy is usually not indicated for diagnosis. Nephrotic syndrome GIVE FEEDBACK F Normal light microscopy findings Minimal change disease EXIT SESSION PREVIOUS NEXT T STUDENT Ctrl+K Ask a medical question pitting edema Albugin 215/01 To tal cholesterol 290 ms/dl Protein At
  • 17.
    SHOW ALL EXPLANATIONSRESET QUESTION HIDE STATS 7% G Granular subepithelial deposits of IgG, IgM, and C3 on immunofluorescence 1% H Apple-green birefringence with Congo red stain 23% I Effacement of foot processes of podocytes on light microscopy 0% J Segmental sclerosis on light microscopy Nephrotic syndrome GIVE FEEDBACK EXIT SESSION PREVIOUS NEXT
  • 18.
    A 17-year-old boyis brought to the physician because of swelling of his face and legs for 5 days. He immigrated to the United States from Korea with his family 10 years ago. He has been healthy except for an episode of sore throat 2 weeks ago. His younger sister has type 1 diabetes mellitus. His temperature is 37.0°C (98.6°F), pulse is 90/min, and blood pressure is 145/87 mm Hg. Examination shows periorbital edema and 3+ piRing edema of the lower extremities. Laboratory studies show: Further evaluation is most likely to show which of the following additional findings? ADD NOTES MARK GET ANKI CARDS HINT USED This boy has features of , i.e., swelling of the face and extremities, , and heavy (4+ on ), and that is positive for . frequently occurs in association with , which is more common in some African and Asian countries (e.g., China and Korea). GIVE FEEDBACK Hemoglobin 13.9 g/dL Leukocyte count 8100/mm Serum Glucose 78 mg/dL Albumin 2.4 g/dL Hepatitis B surface antigen positive Hepatitis B surface antibody negative Complement C4 decreased Urine Blood negative Protein 4+ Glucose negative Protein/creatinine ratio 8.1 (N ≤ 0.2) 3 KEY INFO ATTENDING TIP LABS nephrotic syndrome hypoalbuminemia proteinuria urine dipstick serology hepatitis B Membranous nephropathy hepatitis B 2% B Eosinophilic nodules on renal biopsy 47% Subepithelial deposits of IgG and complement along the glomerular basement membrane (spike and dome appearance) are the classic finding in membranous nephropathy. The deposits can be seen on immunofluorescence microscopy and electron microscopy. In secondary membranous nephropathy, subendothelial deposits are also commonly seen. While membranous nephropathy is the most common cause of nephrotic syndrome in white adults, it is rare in the pediatric population. However, there are certain factors that increase the risk of membranous nephropathy in children and adolescents as well, such as early hepatitis B infection, transmiRed either vertically or horizontally. While membranoproliferative glomerulonephritis (MPGN) is also associated with hepatitis B, it is less common than membranous nephropathy and would show spliRing of basement membrane on renal biopsy. Nephrotic syndrome GIVE FEEDBACK A Subepithelial deposits on renal biopsy Membranous nephropathy EXIT SESSION PREVIOUS NEXT T STUDENT Ctrl+K Ask a medical question swelling of his face and legs Korea Albimin 2 . 48/dL Hepatitis B surface antigen + Ve Protein 44 Protein -
  • 19.
    SHOW ALL EXPLANATIONSRESET QUESTION HIDE STATS 2% B Eosinophilic nodules on renal biopsy 17% C Antistreptolysin O titers in serum 4% D Antineutrophil cytoplasmic antibody level in serum 26% E Normal-appearing glomeruli on renal biopsy 5% F Increased IgA levels in serum EXIT SESSION PREVIOUS NEXT - -
  • 20.
    HINT USED A 7-year-oldboy is brought to the physician by his mother for evaluation of progressively worsening swelling around the eyes. He has no history of major medical illness. He had a sore throat and cough 2 weeks ago that resolved spontaneously. Physical examination shows moderate periorbital edema and 2+ piBing edema of the lower extremities bilaterally. A kidney biopsy specimen shows effacement of the podocytes on electron microscopy. Which of the following is most likely to be found on urinalysis? ADD NOTES MARK GET ANKI CARDS HINT USED This patient's finding of effacement of the indicates ( ), the most common cause of in children. A presentation of periorbital and a couple weeks a?er a potential viral infection (i.e., ) is consistent with this diagnosis. GIVE FEEDBACK SHOW ALL EXPLANATIONS RESET QUESTION HIDE STATS KEY INFO ATTENDING TIP LABS biopsy podocytes minimal change disease MCD nephrotic syndrome lower extremity edema sore throat 9% A Hyaline casts and immunoglobulins 12% B Red blood cell casts and acanthocytes 3% D White blood cell casts and eosinophils 4% E Granular casts and tubular epithelial cells 71% FaBy casts and albumin are the expected findings in MCD, in which structural damage to the podocytes and loss of the GBM negative charge results in a loss of protein (specifically, anionic albumin) into the urine. To compensate for the renal loss of albumin, the liver increases lipoprotein synthesis. Lipids are then seen in the urine as faBy casts because of the increased glomerular permeability. Nephrotic syndrome GIVE FEEDBACK C FaBy casts and albumin EXIT SESSION PREVIOUS NEXT T STUDENT Ctrl+K Ask a medical question swelling around the eyes. effacement of the podocytes on electron microscopy
  • 21.
    An 8-year-old boyis brought to the office because of bilateral ankle swelling that occurred overnight. He has stopped wearing socks because they feel too tight. He has type 1 diabetes mellitus treated with insulin. He has received all scheduled immunizations. His temperature is 37.0°C (98.6°F), pulse is 90/min, respirations are 16/min, and blood pressure is 112/75 mm Hg. Cardiopulmonary and abdominal examinations show no abnormalities. There is moderate scrotal edema, and 2+ piQing edema of the lower extremities. Laboratory studies show: Treatment with prednisone is begun. Over the following weeks, there is a significant improvement in the patient's peripheral edema and urinalysis findings. Which of the following is the most likely diagnosis? ADD NOTES MARK GET ANKI CARDS HINT USED This patient's history of , , , and on indicates . In this patient, a would most likely show with a normal appearance on light microscopy and effacement of foot processes on . GIVE FEEDBACK Hemoglobin 13.5 g/dL Leukocyte count 5000/mm Platelet count 240,000/mm Serum Urea nitrogen 36 mg/dL Glucose 77 mg/dL Creatinine 0.8 mg/dL Albumin 2.6 mg/dL Urine Blood negative Glucose negative Protein 4+ RBC none WBC 0–1/hpf FaQy casts numerous 3 3 KEY INFO ATTENDING TIP LABS edema hypoalbuminemia proteinuria fa5y casts urinalysis nephrotic syndrome renal biopsy glomeruli podocyte electron microscopy 2% A Nodular glomerulosclerosis 2% B Membranoproliferative glomerulonephritis 1% C IgA nephropathy 2% E Focal segmental glomerulosclerosis 89% Minimal change disease (MCD) is the most common cause of nephrotic syndrome in children. Immunosuppressive therapy is recommended for all patients with MCD; glucocorticoid therapy (e.g., with prednisone) is considered the first-line treatment, as most patients improve with this regimen alone. If complete remission does not occur, higher doses of steroid therapy or alternative immunosuppressive agents (e.g., cyclophosphamide, calcineurin inhibitors) may be needed. Edema should be controlled by sodium restriction and careful monitoring of fluid input and output. MCD has also been associated with hematologic malignancies (e.g., Hodgkin lymphoma). Nephrotic syndrome GIVE FEEDBACK D Minimal change disease EXIT SESSION PREVIOUS SEE ANALYSIS T STUDENT Ctrl+K Ask a medical question 8-year-old boy moderate scrotal edema bilateral ankle swelling 2+ piQing edema of the lower extremities Treatment with prednisone Albumin 2 , 6 mild Protein 4t fatty casts numerous
  • 22.
    SHOW ALL EXPLANATIONSRESET QUESTION HIDE STATS 2% E Focal segmental glomerulosclerosis 5% F Membranous nephropathy EXIT SESSION PREVIOUS SEE ANALYSIS